tradingkey.logo

Neuropace Inc

NPCE
16.020USD
-0.170-1.05%
收盤 12/26, 16:00美東報價延遲15分鐘
533.16M總市值
虧損本益比TTM

Neuropace Inc

16.020
-0.170-1.05%

關於 Neuropace Inc 公司

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Neuropace Inc簡介

公司代碼NPCE
公司名稱Neuropace Inc
上市日期Apr 22, 2021
CEOBecker (Joel D)
員工數量184
證券類型Ordinary Share
年結日Apr 22
公司地址455 N. Bernardo Avenue
城市MOUNTAIN VIEW
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94043
電話16502372700
網址https://www.neuropace.com/
公司代碼NPCE
上市日期Apr 22, 2021
CEOBecker (Joel D)

Neuropace Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
591.92K
+0.41%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
64.90K
-2.02%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
38.48K
+3.03%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
17.10K
+9.68%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
13.23K
+9.92%
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
591.92K
+0.41%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
64.90K
-2.02%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
38.48K
+3.03%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
17.10K
+9.68%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
13.23K
+9.92%

收入明細

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q1
FY2023
FY2022
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
23.52M
0.00%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Accelmed Growth Partners Management Ltd
13.40%
Polar Capital LLP
9.36%
Soleus Capital Management, L.P.
8.94%
OrbiMed Advisors, LLC
7.90%
Morgan Stanley & Co. LLC
7.67%
其他
52.72%
持股股東
持股股東
佔比
Accelmed Growth Partners Management Ltd
13.40%
Polar Capital LLP
9.36%
Soleus Capital Management, L.P.
8.94%
OrbiMed Advisors, LLC
7.90%
Morgan Stanley & Co. LLC
7.67%
其他
52.72%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
26.09%
Private Equity
21.30%
Hedge Fund
19.37%
Investment Advisor
17.07%
Research Firm
8.41%
Individual Investor
2.71%
Pension Fund
0.29%
Bank and Trust
0.08%
Venture Capital
0.03%
其他
4.66%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
198
31.14M
94.13%
-2.95M
2025Q2
184
29.13M
88.81%
-1.17M
2025Q1
183
29.76M
92.98%
+2.27M
2024Q4
144
26.53M
86.07%
-49.99K
2024Q3
134
26.01M
86.62%
-1.02M
2024Q2
129
25.88M
90.53%
+502.69K
2024Q1
131
24.82M
87.55%
-513.24K
2023Q4
113
24.06M
92.70%
-1.70M
2023Q3
103
24.86M
97.20%
-1.10M
2023Q2
106
24.30M
96.22%
-2.15M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Accelmed Growth Partners Management Ltd
4.43M
13.4%
--
--
Apr 09, 2025
Soleus Capital Management, L.P.
2.31M
6.99%
-295.21K
-11.32%
Jun 30, 2025
OrbiMed Advisors, LLC
2.61M
7.9%
-792.15K
-23.26%
Jun 30, 2025
Morgan Stanley & Co. LLC
2.58M
7.79%
+52.63K
+2.08%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.54M
4.64%
+803.81K
+109.91%
Jun 30, 2025
The Vanguard Group, Inc.
1.37M
4.14%
+171.20K
+14.29%
Jun 30, 2025
First Light Asset Management, LLC
1.38M
4.17%
-203.64K
-12.86%
Jun 30, 2025
Armistice Capital LLC
1.15M
3.48%
-1.28K
-0.11%
Jun 30, 2025
Kent Lake PR LLC
925.00K
2.8%
-25.00K
-2.63%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Neuroscience and Healthcare ETF
0.64%
Principal U.S. Small-Cap ETF
0.05%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Proshares Ultra Russell 2000
0.01%
查看更多
iShares Neuroscience and Healthcare ETF
佔比0.64%
Principal U.S. Small-Cap ETF
佔比0.05%
iShares Micro-Cap ETF
佔比0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.02%
ProShares Hedge Replication ETF
佔比0.02%
ProShares UltraPro Russell2000
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Neuropace Inc的前五大股東是誰?

Neuropace Inc的前五大股東如下:
Accelmed Growth Partners Management Ltd
持有股份:4.43M
佔總股份比例:13.40%。
Soleus Capital Management, L.P.
持有股份:2.31M
佔總股份比例:6.99%。
OrbiMed Advisors, LLC
持有股份:2.61M
佔總股份比例:7.90%。
Morgan Stanley & Co. LLC
持有股份:2.58M
佔總股份比例:7.79%。
BlackRock Institutional Trust Company, N.A.
持有股份:1.54M
佔總股份比例:4.64%。

Neuropace Inc的前三大股東類型是什麼?

Neuropace Inc 的前三大股東類型分別是:
Accelmed Growth Partners Management Ltd
Polar Capital LLP
Soleus Capital Management, L.P.

有多少機構持有Neuropace Inc(NPCE)的股份?

截至2025Q3,共有198家機構持有Neuropace Inc的股份,合計持有的股份價值約為31.14M,占公司總股份的94.13% 。與2025Q2相比,機構持股有所增加,增幅為5.32%。

哪個業務部門對Neuropace Inc的收入貢獻最大?

在FY2025Q2,--業務部門對Neuropace Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI